The inflammasome pathway in stable COPD and acute exacerbations

ERJ Open Research

Volumn 2, Issue 3, 2016, Pages

  Faner, Rosa ^a,b   Sobradillo, Patricia ^b,c   Noguera, Aina ^b,d   Gomez, Cristina ^d   Cruz, Tamara ^a,b   López Giraldo, Alejandra ^a,b   Ballester, Eugeni ^e,f   Soler, Nestor ^e,f   Arostegui, Juan I ^e,f   Pelegrín, Pablo ^g   Rodriguez Roisin, Roberto ^b,e,f   Yagüe, Jordi ^e,f   Cosio, Borja G ^b,d   Juan, Manel ^e,f   Agustí, Alvar ^a,b,e,f  

^a Fundacio Clinic Per a la Recerca Biomedica   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85017442552     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00002-2016     Document Type: Article

References (32)

1. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
2. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
3. Perera WR, Hurst JR, Wilkinson TM, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29: 527-534.
4. Yazdi AS, Guarda G, Riteau N, et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci USA 2010; 107: 19449-19454.
5. Gasse P, Mary C, Guenon I, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007; 117: 3786-3799.
6. Lucattelli M, Cicko S, Muller T, et al. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 2011; 44: 423-429.
7. Gasse P, Riteau N, Charron S, et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 2009; 179: 903-913.
8. Riteau N, Gasse P, Fauconnier L, et al. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 2010; 182: 774-783.
9. Cassel SL, Eisenbarth SC, Iyer SS, et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008; 105: 9035-9040.
10. Lommatzsch M, Cicko S, Muller T, et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 928-934.
11. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34: 50s-59s.
12. Gessner C, Scheibe R, Wotzel M, et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 2005; 99: 1229-1240.
13. Di Stefano A, Caramori G, Barczyk A, et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax 2014; 69: 516-524.
14. Villena C, Pozo F, Barbera JA, et al. The CIBERES Pulmonary Biobank Consortium: an opportunity for cooperative international respiratory research. Eur Respir J 2011; 37: 204-206.
15. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
16. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
18. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 5 Suppl. 2, 398S-401S.
19. Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662-671.
20. Baroja-Mazo A, Martin-Sanchez F, Gomez AI, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014; 15: 738-748.
21. Franklin BS, Bossaller L, De Nardo D, et al. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol 2014; 15: 727-737.
22. Franchi L, Nunez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol 2008; 38: 2085-2089.
23. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009; 183: 792-796.
24. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
25. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.
26. Stutz A, Horvath GL, Monks BG, et al. ASC speck formation as a readout for inflammasome activation. Methods Mol Biol 2013; 1040: 91-101.
27. Lu A, Magupalli VG, Ruan J, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014; 156: 1193-1206.
28. Cai X, Chen J, Xu H, et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014; 156: 1207-1222.
29. Lee JK, Kim SH, Lewis EC, et al. Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci USA 2004; 101: 8815-8820.
30. Sarkar A, Mitra S, Mehta S, et al. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One 2009; 4: e7140.
31. Laliberte RE, Eggler J, Gabel CA. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J Biol Chem 1999; 274: 36944-36951.
32. Eltom S, Stevenson CS, Rastrick J, et al. P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One 2011; 6: e24097.